XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of components and classification of financial assets and liabilities measured at fair value
The following fair value hierarchy table presents the components and classification of the Company’s financial assets and liabilities measured at fair value on a recurring basis:
 September 30, 2025December 31, 2024
(in millions)TotalLevel 1Level 2Level 3TotalLevel 1Level 2Level 3
Assets:        
Cash equivalents$432 $427 $$— $567 $557 $10 $— 
Restricted cash$32 $32 $— $— $20 $20 $— $— 
Cross-currency swaps$$— $$— $$— $$— 
Foreign currency exchange contracts$$— $$— $10 $— $10 $— 
Liabilities:     
Acquisition-related contingent consideration$263 $— $— $263 $359 $— $— $359 
Cross-currency swaps$156 $— $156 $— $40 $— $40 $— 
Foreign currency exchange contracts$$— $$— $$— $$— 
Schedule of assets and liabilities associated with derivatives, included in the Consolidated Balance Sheets
The assets and liabilities associated with Bausch + Lomb’s cross-currency swaps as included in the Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 are as follows:
(in millions)September 30,
2025
December 31,
2024
Other non-current liabilities$(156)$(40)
Prepaid expenses and other current assets$$
Net fair value$(154)$(34)
The assets and liabilities associated with the Company’s foreign exchange contracts as included in the Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 are as follows:
(in millions)September 30,
2025
December 31,
2024
Accrued and other current liabilities$(2)$(5)
Prepaid expenses and other current assets$$10 
Net fair value$— $
Schedule of effect of hedging instruments on financial statements
The following table presents the effect of hedging instruments on the Condensed Consolidated Statements of Comprehensive Income (loss) and the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2025202420252024
Gain (loss) recognized in Other comprehensive income (loss)$12 $(33)$(116)$(7)
Gain excluded from assessment of hedge effectiveness$$$$10 
Location of gain of excluded componentInterest ExpenseInterest Expense
Schedule of foreign exchange contracts on the Consolidated Statements of Operations and Consolidated Statements of Cash Flows
The following table presents the effect of the Company’s foreign exchange contracts on the Condensed Consolidated Statements of Operations and the Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2025 and 2024:
Three Months Ended September 30,Nine Months Ended
September 30,
(in millions)2025202420252024
Gain (loss) related to changes in fair value$$(3)$(5)$(2)
Loss related to settlements$(2)$(2)$(15)$— 
Schedule of reconciliation of contingent consideration obligations measured on a recurring basis using significant unobservable inputs (Level 3)
The following table presents a reconciliation of contingent consideration obligations measured on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended September 30, 2025 and 2024:
September 30,
(in millions)20252024
Balance, beginning of period$359 $292 
Adjustments to Acquisition-related contingent consideration:
Accretion for the time value of money$20 $14 
Fair value adjustments due to changes in estimates of future payments(92)
Acquisition-related contingent consideration (Note 4)(72)19 
Additions— 
Payments/Settlements(24)(27)
Balance, end of period263 285 
Current portion included in Accrued and other current liabilities39 37 
Non-current portion included in Other non-current liabilities$224 $248